KROS · Keros Therapeutics, Inc.
$10.14
-0.07 (-0.69%)
At close · Jul 23
Market Cap
$200.69M
Shares
19.79M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-06-11 | Newton Charles W. | Director | 550 | 2026-06-11 | UBS Financial Services, Inc. |
| 2026-06-04 | Knowles Julius | Director | 2,625 | 2026-06-04 | UBS Financial Services, Inc. |
| 2026-06-04 | Farzan Nima | Director | 2,625 | 2026-06-04 | UBS Financial Services, Inc. |
| 2026-06-04 | Seth Alpna | Director | 2,625 | 2026-06-04 | UBS Financial Services, Inc. |
| 2026-03-31 | OrbiMed Genesis Master Fund, LP | Shareholder, Director | 45,057 | 2026-03-31 | Themis Trading LLC |
| 2025-09-12 | Rovaldi Christopher | Affiliate | 85,306 | 2025-09-12 | UBS Financial Services Inc. |
| 2024-08-13 | OrbiMed Genesis Master Fund, LP | Shareholder, Director | 29,400 | 2024-08-13 | Morgan Stanley Smith Barney |
| 2024-08-13 | OrbiMed Private Investments VII, LP | Shareholder, Director | 220,600 | 2024-08-13 | Morgan Stanley Smith Barney |
| 2024-01-04 | Regnante Keith | Officer | 40,000 | 2024-01-04 | UBS Financial Services, Inc. |
| 2023-12-11 | The Biotech Growth Trust PLC | Shareholder | 246,000 | 2023-12-11 | Themis Trading LLC |
| 2023-06-12 | The Biotech Growth Trust PLC | Shareholder | 170,000 | 2023-06-12 | Evercore ISI |
| 2023-06-09 | Regnante Keith | Officer | 20,000 | 2023-06-09 | UBS Financial Services, Inc. |
| 2023-06-08 | Regnante Keith | Officer | 20,000 | 2023-06-08 | UBS Financial Services, Inc. |
Showing 1–13 of 13 filings
Key facts
CIK
1664710
CUSIP
492327101
13F (30d)
18 filings
17 filers
Visit website
Investor relations